1. Home
  2. BAP vs IQV Comparison

BAP vs IQV Comparison

Compare BAP & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Credicorp Ltd.

BAP

Credicorp Ltd.

HOLD

Current Price

$377.27

Market Cap

30.5B

Sector

Finance

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

N/A

Current Price

$259.99

Market Cap

35.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BAP
IQV
Founded
1889
1982
Country
Peru
United States
Employees
N/A
93000
Industry
Major Banks
Biotechnology: Commercial Physical & Biological Resarch
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.5B
35.1B
IPO Year
1997
2013

Fundamental Metrics

Financial Performance
Metric
BAP
IQV
Price
$377.27
$259.99
Analyst Decision
Buy
Strong Buy
Analyst Count
5
16
Target Price
$309.60
$227.13
AVG Volume (30 Days)
251.6K
1.4M
Earning Date
05-14-2026
05-05-2026
Dividend Yield
3.46%
N/A
EPS Growth
N/A
4.67
EPS
N/A
1.61
Revenue
N/A
$9,739,000,000.00
Revenue This Year
$23.26
$6.77
Revenue Next Year
$8.62
$5.89
P/E Ratio
$12.91
$159.10
Revenue Growth
N/A
41.60
52 Week Low
$230.45
$154.50
52 Week High
$423.17
$260.30

Technical Indicators

Market Signals
Indicator
BAP
IQV
Relative Strength Index (RSI) 47.65 72.36
Support Level $316.70 $218.57
Resistance Level $380.20 N/A
Average True Range (ATR) 12.27 7.66
MACD -2.01 0.61
Stochastic Oscillator 34.37 96.77

Price Performance

Historical Comparison
BAP
IQV

About BAP Credicorp Ltd.

Credicorp Ltd is a Peruvian financial services company. The company operates in four business lines, including Universal Banking, Insurance and Retirement, Microfinance, and Investment Banking and Asset Management. Its subsidiaries include Banco de Credito del Peru, Prima AFP, Credicorp Capital, and others. Geographically, the company operates in Peru, Colombia, Bolivia, Chile, Panama, the USA, and Mexico; the majority of its revenue is generated from Peru.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its research and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: